Suivre
Gaylord Tallec
Gaylord Tallec
Theraclion
Adresse e-mail validée de theraclion.com
Titre
Citée par
Citée par
Année
Synthesis and structure–activity relationships of C-glycosylated oxadiazoles as inhibitors of glycogen phosphorylase
M Tóth, S Kun, É Bokor, M Benltifa, G Tallec, S Vidal, T Docsa, P Gergely, ...
Bioorganic & medicinal chemistry 17 (13), 4773-4785, 2009
902009
Highly stable and soluble bis-aqua Gd, Nd, Yb complexes as potential bimodal MRI/NIR imaging agents
G Tallec, D Imbert, PH Fries, M Mazzanti
Dalton Transactions 39 (40), 9490-9492, 2010
472010
High relaxivity and stability of a hydroxyquinolinate-based tripodal monoaquagadolinium complex for use as a bimodal MRI/optical imaging agent
G Tallec, PH Fries, D Imbert, M Mazzanti
Inorganic Chemistry 50 (17), 7943-7945, 2011
362011
Highly relaxing gadolinium based MRI contrast agents responsive to Mg 2+ sensing
S Abada, A Lecointre, M Elhabiri, D Esteban-Gómez, C Platas-Iglesias, ...
Chemical communications 48 (34), 4085-4087, 2012
322012
Lanthanide-chelate silica nanospheres as robust multicolor Vis-NIR tags
J Samuel, G Tallec, P Cherns, WL Ling, O Raccurt, O Poncelet, D Imbert, ...
Chemical communications 46 (15), 2647-2649, 2010
262010
Confinement of a tris-aqua Gd (III) complex in silica nanoparticles leads to high stability and high relaxivity and supresses anion binding
MM Karimdjy, G Tallec, PH Fries, D Imbert, M Mazzanti
Chemical Communications 51 (31), 6836-6838, 2015
162015
Nouveaux complexes de lanthanides pour le développement d'agents de contraste bimodaux IRM/luminescence
G Tallec
Grenoble, 2011
2011
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–7